About one third of all American adults have prediabetes, an astonishing 88 million Americans, according to the criteria developed by the American…
Category: Oral Medication
Over the past 6 weeks multiple companies have issued recalls for extended-release metformin, the oral diabetes medicine used to help control…
Researchers Raise Doubt Over Major Diabetes Drug Trials
The FDA requires pharmaceutical companies developing diabetes drugs to run trials to…
SGLT2 inhibitors are a class of drugs that are approved to lower the blood glucose levels of people with Type 2 diabetes. Doctors have identified…
TheU.S. FDA has approved Rybelsus (semaglutide), the first and only glucagon-like peptide-1 (GLP-1) analog in a pill.
“GLP-1 receptor agonists…
The FDA has denied approval of Sanofi and Lexicon’s drug, sotagliflozin, as an add-on to insulin therapy in the treatment of Type 1 diabetes.…
The coming year promises to be a busy one for innovations in diabetes tech and medicine. Here are ten things currently in development that may become…
Metformin protects the hearts of people with Type 1 diabetes, according to the results of the MERIT clinical trial. Metformin is an inexpensive…
People with diabetes who take a class of drugs known as sodium–glucose cotransporter 2 (SGLT2) inhibitors will now need to weigh benefits against…
The first time I took Afrezza––an inhalable fast-acting insulin––in public, it was at Wildair, a small, hip restaurant in Manhattan. I inhaled…